A comparison of two measures of quality of life: their sensitivity and validity for patients with advanced cancer - PubMed (original) (raw)
A comparison of two measures of quality of life: their sensitivity and validity for patients with advanced cancer
I J Higginson et al. Palliat Med. 1994 Oct.
Abstract
We compared two measures that have been used by professionals to assess the quality of life and care of patients with advanced cancer. The Support Team Assessment Schedule (STAS) is an instrument for palliative cancer support teams to record and evaluate their care; the Hebrew Rehabilitation Centre for the Aged Quality of Life (HRCA-QL) index was used in the National Hospice Study (USA) to assess patients with advanced cancer. STAS has 17 items, each scaled 0 (best) to 4 (worst), and HRCA-QL has five items scaled 0 (worst) to 2 (best). The STAS and the HRCA-QL were assessed contemporaneously by the members of one support team on 128 consecutive patients referred over 17 months. Seventy-four patients spent more than four weeks in care. Ratings for four out of five HRCA-QL items deteriorated significantly in the four to six weeks before death. HRCA-QL index items correlated with similar STAS items. Correlations were highest at referral, especially in patients seen more than four weeks before death (e.g. symptom control (STAS) with health (HRCA-QL) Spearman's rho = -0.64) and the HRCA-QL total was correlated with STAS subtotal of six items (rho = -0.45). There were few correlations at death. The findings support the validity of both measures for the aspects compared, but indicated that STAS was more sensitive to changes in patients in the last six weeks of life.
Similar articles
- Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index.
Llobera J, Esteva M, Benito E, Terrasa J, Rifà J, Pons O, Maya A. Llobera J, et al. Support Care Cancer. 2003 May;11(5):294-303. doi: 10.1007/s00520-003-0455-7. Epub 2003 Mar 22. Support Care Cancer. 2003. PMID: 12690543 - Validity of the support team assessment schedule: do staffs' ratings reflect those made by patients or their families?
Higginson IJ, McCarthy M. Higginson IJ, et al. Palliat Med. 1993;7(3):219-28. doi: 10.1177/026921639300700309. Palliat Med. 1993. PMID: 7505183 - Effectiveness of two palliative support teams.
Higginson IJ, Wade AM, McCarthy M. Higginson IJ, et al. J Public Health Med. 1992 Mar;14(1):50-6. J Public Health Med. 1992. PMID: 1376133 - The use of two common palliative outcome measures in clinical care and research: a systematic review of POS and STAS.
Bausewein C, Le Grice C, Simon S, Higginson I; PRISMA. Bausewein C, et al. Palliat Med. 2011 Jun;25(4):304-13. doi: 10.1177/0269216310395984. Epub 2011 Apr 4. Palliat Med. 2011. PMID: 21464119 Review.
Cited by
- The development of the Canberra symptom scorecard: a tool to monitor the physical symptoms of patients with advanced tumours.
Barresi MJ, Shadbolt B, Byrne D, Stuart-Harris R. Barresi MJ, et al. BMC Cancer. 2003 Dec 17;3:32. doi: 10.1186/1471-2407-3-32. BMC Cancer. 2003. PMID: 14678564 Free PMC article. - Application of quality audit tools to evaluate care quality received by terminal cancer patients admitted to a palliative care unit.
Tsai LY, Li IF, Liu CP, Su WH, Change TY. Tsai LY, et al. Support Care Cancer. 2008 Sep;16(9):1067-74. doi: 10.1007/s00520-007-0365-1. Epub 2008 Jan 15. Support Care Cancer. 2008. PMID: 18196292 - Measuring quality of life: Using quality of life measures in the clinical setting.
Higginson IJ, Carr AJ. Higginson IJ, et al. BMJ. 2001 May 26;322(7297):1297-300. doi: 10.1136/bmj.322.7297.1297. BMJ. 2001. PMID: 11375237 Free PMC article. No abstract available. - Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index.
Llobera J, Esteva M, Benito E, Terrasa J, Rifà J, Pons O, Maya A. Llobera J, et al. Support Care Cancer. 2003 May;11(5):294-303. doi: 10.1007/s00520-003-0455-7. Epub 2003 Mar 22. Support Care Cancer. 2003. PMID: 12690543 - Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment.
Michael M, Tannock IF. Michael M, et al. CMAJ. 1998 Jun 30;158(13):1727-34. CMAJ. 1998. PMID: 9676550 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources